Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-31 BENNETT C FRANK EVP, Chief Scientific Officer Sale −1,327 $32.46 $43K 93,146
2025-01-30 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award +3,607 94,473
2025-01-16 BENNETT C FRANK EVP, Chief Scientific Officer Sale −6,752 $32.90 $222K 90,866
2025-01-15 BENNETT C FRANK EVP, Chief Scientific Officer Exercise or conversion +18,011 97,618
2025-01-15 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Performance Restricted Stock Units +22,000 63,482
2025-01-15 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Restricted Stock Unit +33,000 56,500
2025-01-15 BENNETT C FRANK EVP, Chief Scientific Officer Exercise or conversion · Restricted Stock Unit −18,011 38,489
2025-01-02 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2024-08-30 BENNETT C FRANK EVP, Chief Scientific Officer Other acquisition +177 $38.64 $7K 79,607
2024-02-29 BENNETT C FRANK Officer Level 14 Other acquisition +383 $34.43 $13K 79,462
2024-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Sale −1,885 $49.52 $93K 79,047
2024-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Sale −1,853 $49.52 $92K 79,079
2024-02-01 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award +3,609 80,932
2024-01-17 BENNETT C FRANK EVP, Chief Scientific Officer Sale −6,745 $50.42 $340K 77,323
2024-01-16 BENNETT C FRANK EVP, Chief Scientific Officer Exercise or conversion +18,314 84,068
2024-01-16 BENNETT C FRANK EVP, Chief Scientific Officer Exercise or conversion · Restricted Stock Unit −18,314 23,500
2024-01-15 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Performance Restricted Stock Units +17,000 41,482
2024-01-15 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Restricted Stock Unit +20,400 41,814
2024-01-02 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Non-Qualified Stock Option (right to buy) +27,200 27,200
2023-12-21 BENNETT C FRANK EVP, Chief Scientific Officer Exercise or conversion 10b5-1 +16,113 $47.34 $763K 81,867

Page 3 of 5 · 82 trades